of Diseases Treated by
Treatment of Untreatable Male and Female Infertility by BCRO Fetal Precursor Cell Transplantation
Male infertility is in 50% of instances a cause of the infertility of a couple.
The success rate of treatment of male infertility, in particular of azoospermia, the lack of sperm, or of oligospermia, 'too little sperm', or damaged sperm, etc., with modern medical therapies, has been close to zero forcing the childless couple to resort to the sperm donors in order to have a child of their own.
With progress of in-vitro-fertilization techniques, male infertility has become a substantially more serious problem than female infertility.
It is not surprising that fetal precursor cell transplantation has been tried in such desperate situations.
In our experience with a few patients with azoospermia the treatment by BCRO cell transplantation alone had a very low success rate,
but subsequently a technique was developed, that makes a scientific sense and should be tried in some well selected patients. We learned that one must not confuse the effect of hormone substitution withnthat of fetal precursor cell transplantation.
Beware that injections of testosterone that have been used excessively lately, will cause atrophy of testicles by a competitive inhibition. If the function of your testes is diminished by getting testosterone injections you will eliminate the function of your testes completely!
Male and female menopause are not the same. In females the function of ovaries is extinguished in menopause, in men the function of testes is never eliminated.
Endocrinologists usually overdose the patients with hormones, 'more is better',. Even more so medical hucksters selling testosterone injections to the gullible men.
Overdosing is highly inadvisable with fetal precursor cell transplantation as well:
1/ if the 1st BCRO fetal precursor cell transplantation was not succesful, the 2nd one must be postponed for 6 to 9 monthd, and
2/ it is mandatory to treat the entire regulatory circuit, i.e. hypothalamus, pituitary and respective endocrine glands.
This protocol requires a full cooperation of an infertility clinic.
After a complete diagnostic evaluation BCRO fetal precursor cell transplantation is carried out in order to
After a month or so patientís ejaculate has to be collected every week for 4 weeks, and inspected for normal, mobile, spermatozoa. If any such spermatozoa are found, they have to be concentrated, and eventually frozen.
When a sufficient quantity of spermatozoa is accumulated, an artificial insemination is carried out, and repeated as necessary.
As a male is usually not happy with the idea that his child would not be really his, before electing to use a sperm of a donor for in-vitro-fertilization, a trial of the above method should be offered.
In female infertility there are situations in medical practice, when in-vitro-fertilization had not worked, and repeatedly so, for reasons that cannot be elucidated by even the most sophisticated diagnostic methods and testing.
BCRO fetal precursor cell transplantation should be considered in such instances, followed in 4 weeks by another in-vitro-fertilization attempt.
Even though the medical reports about such approach are hard to find, this has been a well guarded secret of many gynecologists dealing with infertility long before in-vitro-fertilization came into existence.
The use of BCRO fetal precursor cell transplantation for the treatment of infertility can be studied in a textbook of E. Michael Molnar, M.D. "Stem Cell Transplantation, a Textbook of Stem Cell Xeno-Transplantation", published by Medical And Engineering Publishers, Inc., Washington, D.C., in February 2006, the first textbook for medical profession and students in the world about this subject. Click on www.mepublishers.com On the same web site you can can find the latest book by the same author: 'Treatment of Incurable and Untreatable Diseases', published for general readership by the same publisher in November 2012.
|ABOUT BCRO||WARRANTY/REPLACEMENT||DISCLAIMER||PRIVACY STATEMENT|
|Copyright Stem Cell Transplantation Ltd.|
|Updated: April 2014|